Imaging spectrum of adverse events of immune checkpoint inhibitors.
Adrenal Gland Diseases
/ diagnostic imaging
Colitis
/ diagnostic imaging
Encephalitis
/ diagnostic imaging
Hepatitis
/ diagnostic imaging
Humans
Immune Checkpoint Inhibitors
/ adverse effects
Myocarditis
/ diagnostic imaging
Neoplasms
/ diagnostic imaging
Pancreatitis
/ diagnostic imaging
Pericarditis
/ diagnostic imaging
Pneumonia
/ diagnostic imaging
Sarcoidosis
/ diagnostic imaging
Thyroiditis
/ diagnostic imaging
Journal
Clinical radiology
ISSN: 1365-229X
Titre abrégé: Clin Radiol
Pays: England
ID NLM: 1306016
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
18
08
2020
accepted:
20
11
2020
pubmed:
31
12
2020
medline:
12
8
2021
entrez:
30
12
2020
Statut:
ppublish
Résumé
Immune checkpoint inhibitors (ICIs), a form of immunotherapy, are increasingly used for a variety of malignancies and have been linked to numerous treatment-related side effects known as immune-related adverse events (irAEs). IrAEs can affect multiple organ systems and are important to recognise in order to avoid misinterpretation as progressive tumour and to ensure appropriate management. In this pictorial review, we will briefly discuss radiological response criteria of immunotherapy and describe the imaging appearances of the wide spectrum of these ICI-associated toxicities.
Identifiants
pubmed: 33375984
pii: S0009-9260(20)30625-5
doi: 10.1016/j.crad.2020.11.117
pii:
doi:
Substances chimiques
Immune Checkpoint Inhibitors
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
262-272Informations de copyright
Copyright © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.